Authors:
KIRKLEY SA
COWLES J
PELLEGRINI VD
HARRIS CM
BOYD AD
BLUMBERG N
Citation: Sa. Kirkley et al., BLOOD-TRANSFUSION AND TOTAL JOINT REPLACEMENT SURGERY - T-HELPER-2 (TH2) CYTOKINE SECRETION AND CLINICAL OUTCOME, TRANSFUSION MEDICINE, 8(3), 1998, pp. 195-204
Citation: J. Rios et al., REDUCED MORBIDITY IN PEDIATRIC ACUTE LYMPHOCYTIC-LEUKEMIA WITH LEUKODEPLETED (LD) BLOOD-TRANSFUSIONS, Transfusion, 38(10), 1998, pp. 78-78
Citation: N. Blumberg, PERIOPERATIVE ALLOGENEIC BLOOD-TRANSFUSION DOES NOT CAUSE ADVERSE SEQUELAE IN PATIENTS WITH CANCER - A METAANALYSIS OF UNCONFOUNDED STUDIES- LETTER 2, British Journal of Surgery, 85(8), 1998, pp. 1163-1164
Citation: N. Blumberg et Jm. Heal, BLOOD-TRANSFUSION IMMUNOMODULATION - THE SILENT EPIDEMIC, Archives of pathology and laboratory medicine, 122(2), 1998, pp. 117-119
Citation: N. Blumberg et al., REDUCED MORBIDITY AND MORTALITY IN ACUTE-LEUKEMIA ASSOCIATED WITH LEUKODEPLETED (LD) BLOOD-TRANSFUSIONS, Blood, 90(10), 1997, pp. 679-679
Citation: Jm. Heal et al., INTERACTION OF PLATELET FC AND COMPLEMENT RECEPTORS WITH CIRCULATING IMMUNE-COMPLEXES INVOLVING THE ABO SYSTEM, Vox sanguinis, 71(4), 1996, pp. 205-211
Citation: N. Blumberg et J. Cowles, HYPOTENSION AND ALLOGENEIC TRANSFUSION AS PREDICTORS OF MORBIDITY AFTER CORONARY-ARTERY SURGERY (CABG), Transfusion, 36(9), 1996, pp. 137-137
Citation: N. Blumberg et Jm. Heal, THE TRANSFUSION IMMUNOMODULATION THEORY - THE TH1 TH2 PARADIGM AND ANANALOGY WITH PREGNANCY AS A UNIFYING MECHANISM/, Seminars in hematology, 33(4), 1996, pp. 329-340
Authors:
HASDAI D
VARDABLOOM N
BLUMBERG N
OHAD D
KORNOWSKI R
BATTLER A
Citation: D. Hasdai et al., THE EFFECT OF LOW-MOLECULAR-WEIGHT HEPARIN (FRAGMIN) ON MYOCARDIAL NEUTROPHIL ACCUMULATION AND INFARCT SIZE IN A RAT MODEL OF MYOCARDIAL-INFARCTION, Angiology, 47(5), 1996, pp. 491-499
Citation: N. Blumberg et al., A COST-ANALYSIS OF AUTOLOGOUS AND ALLOGENEIC TRANSFUSIONS IN HIP-REPLACEMENT SURGERY, The American journal of surgery, 171(3), 1996, pp. 324-330
Citation: N. Blumberg et Jm. Heal, IMMUNOMODULATION BY BLOOD-TRANSFUSION - AN EVOLVING SCIENTIFIC AND CLINICAL CHALLENGE, The American journal of medicine, 101(3), 1996, pp. 299-308
Authors:
BLUMBERG N
HEAL JM
KIRKLEY SA
DIPERSIO JF
RAPOPORT AP
ROWE JM
Citation: N. Blumberg et al., LEUKODEPLETED-ABO-IDENTICAL BLOOD COMPONENTS IN THE TREATMENT OF HEMATOLOGIC MALIGNANCIES - A COST-ANALYSIS, American journal of hematology, 48(2), 1995, pp. 108-115
Citation: Jm. Heal et al., INTERACTION OF PLATELET FC AND C1Q RECEPTORS WITH CIRCULATING IMMUNE-COMPLEXES INVOLVING THE ABO SYSTEM, Transfusion, 35(10), 1995, pp. 73-73
Authors:
KIRKLEY S
COWLES J
PELLEGRINI V
HARRIS C
BOYD A
BLUMBERG N
Citation: S. Kirkley et al., T-HELPER-2 (TH2) TYPE CYTOKINE SECRETION FOUND IN SURGICAL PATIENTS RECEIVING ALLOGENEIC BLOOD, Transfusion, 35(10), 1995, pp. 174-174
Citation: D. Hasdai et al., THE NON-ANTITHROMBOTIC THERAPEUTIC POTENTIAL OF HEPARIN AND RELATED HEPARINOIDS IN CARDIOVASCULAR-DISEASES, Coronary artery disease, 5(1), 1994, pp. 81-91
Citation: Jm. Heal et al., POSSIBLE SURVIVAL ADVANTAGE IN ADULTS WITH ACUTE-LEUKEMIA RECEIVING ABO-IDENTICAL PLATELET TRANSFUSIONS, American journal of hematology, 45(2), 1994, pp. 189-190